Daron G. Evans
Net Worth

Last updated:

What is Daron G. Evans net worth?

The estimated net worth of Mr. Daron G. Evans is at least $3,572,214 as of 12 Mar 2020. He owns shares worth $570,414 as insider and has received compensation worth at least $3,001,800 in Nephros, Inc..

What is the salary of Daron G. Evans?

Mr. Daron G. Evans salary is $300,180 per year as Chief Executive Officer of Specialty Renal Products, Inc in Nephros, Inc..

How old is Daron G. Evans?

Mr. Daron G. Evans is 51 years old, born in 1974.

What stocks does Daron G. Evans currently own?

As insider, Mr. Daron G. Evans owns shares in one company:

Company Title Shares Price per share Total value
Nephros, Inc. (NEPH) Chief Executive Officer of Specialty Renal Products, Inc 134,215 $4.25 $570,414

What does Nephros, Inc. do?

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Daron G. Evans insider trading

Nephros, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 2,500 N/A N/A
Purchase
Common Stock 2,500 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 2,000 N/A N/A
Purchase
Common Stock 35,172 $0.6 $21,174
Purchase
Common Stock 35,172 N/A N/A
Purchase
Common Stock 79,000 N/A N/A
Purchase
Common Stock 28,000 N/A N/A
Purchase
Common Stock 1,580 N/A N/A
Purchase
Common Stock 4,000 N/A N/A
Purchase
Common Stock 4,000 $0.25 $1,000
Purchase
Common Stock 70,000 N/A N/A
Purchase
Common Stock 3,961 N/A N/A
Purchase
Common Stock 17,500 N/A N/A
Purchase
Common Stock 7,500 N/A N/A
Purchase
Common Stock 22,500 N/A N/A
Purchase
Common Stock 41,666 N/A N/A
Purchase
Common Stock 4,069 N/A N/A
Purchase
Common Stock 10,620 N/A N/A
Purchase
Common Stock 40,599 N/A N/A
Purchase
Common Stock 931 N/A N/A
Purchase
Common Stock Warrants (Right to Buy) 50,000 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 15,000 N/A N/A
Purchase
Common Stock 15,000 $0.58 $8,625
Purchase
Common Stock 19,175 N/A N/A
Purchase
Common Stock 27,000 N/A N/A
Purchase
Common Stock 24,500 N/A N/A

Nephros key executives

Nephros, Inc. executives and other stock owners filed with the SEC: